Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05215353 · ClinicalTrials.gov registry record · Phase 4

A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

A Phase 4 study of Survivorship, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
Phase 4
Development phase
368
Enrollment target
3
Study locations

NCT05215353 is a Phase 4 study of Survivorship that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 368 participants, above the 220-participant average among 36 other Survivorship trials with a reported enrollment target (67% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05215353, a Phase 4 study of Survivorship, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
Phase 4
Development phase
368 participants
Enrollment target
3
Study locations

Study Summary

The researchers are doing this study to compare how music therapy and cognitive behavioral therapy, given virtually, may be able to reduce anxiety in people who have had cancer. In addition, this study will see if certain factors affect how well participants respond to music therapy or cognitive behavioral therapy. For example, the researchers will see if personal characteristics (like age, sex, race, and education) and ways of thinking (like expectations of therapy) may affect how well participants respond.

Conditions Studied

Interventions

  • OTHER Cognitive Behavioral Therapy
  • OTHER Music Therapy
  • OTHER assessments

Study Locations (3)

Florida

  • Baptist Alliance MCI - Miami

New York

  • Memorial Sloan Kettering Cancer Center - New York

Pennsylvania

  • Drexel University - Philadelphia

Trial Details

FieldValue
Enrollment Target 368 participants
Start Date 2022-01-14
Est. Completion 2027-01
Phase Phase 4

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT05215353

The ClinicalTrials.gov registry entry for NCT05215353 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 368 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 220-participant average among 36 other Survivorship trials with a reported enrollment target (67% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Survivorship appearing as the primary indexed condition, and to 3 interventions - of which Cognitive Behavioral Therapy is the first listed.

NCT05215353 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, New York, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05215353 about?

NCT05215353 is a clinical study titled "A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors". The researchers are doing this study to compare how music therapy and cognitive behavioral therapy, given virtually, may be able to reduce anxiety in people who have had cancer. In addition, this study will see if certain factors affect how well participants respond to music therapy or cognitive beh...

What is the current status of trial NCT05215353?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 368 participants. The study started on 2022-01-14. Estimated completion is 2027-01.

What conditions does trial NCT05215353 study?

This clinical trial studies the following conditions: Survivorship.

What interventions are being tested in trial NCT05215353?

The interventions under investigation include: Cognitive Behavioral Therapy (OTHER), Music Therapy (OTHER), assessments (OTHER).

Who is sponsoring clinical trial NCT05215353?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05215353 being conducted?

This trial has 3 study locations across Florida, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Survivorship

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.